Galson Steven K 4
4 · BIOCRYST PHARMACEUTICALS INC · Filed Sep 2, 2021
Insider Transaction Report
Form 4
Galson Steven K
Director
Transactions
- Award
Non-Qualified Stock Option
2021-09-01+60,000→ 60,000 totalExercise: $16.15Exp: 2031-09-01→ Common Stock (60,000 underlying)
Footnotes (2)
- [F1]Automatic non-employee director grant pursuant to the BioCryst Pharmaceuticals, Inc. Amended and Restated Stock Incentive Plan.
- [F2]The option vests 1/36 per month for a period of 36 months, beginning on October 1, 2021.